On October 8, 2023, the cell bank team at the Beike Biotech Preparation Center's independently developed software system — the "Cell Bank Sample Management System" — passed review by the National Copyright Administration and was issued a Computer Software Copyright Registration Certificate.
The software system is divided into 8 core modules. It manages in-bank samples digitally across the entire process — handover, temporary storage, deposit, and withdrawal — significantly improving operational efficiency on the basis of ensuring the accuracy and security of sample data, and driving the cell bank toward greater digitalization and intelligence. The award of this software copyright is another breakthrough for Beike Biotech in proprietary intellectual property and the translation of scientific and technological achievements, demonstrating the company's core competitiveness in technological innovation, supporting its high-quality development, and enhancing its competitiveness and influence in the specialty technology field.
Going forward, the Beike Biotech Preparation Center will continue to strengthen technological innovation, continuously explore and practice, advance the digitalization of the full life-cycle management of samples, and provide customers with more professional and high-quality services.
About the software
The cell bank team at the Beike Biotech Preparation Center began planning the development of the Cell Bank Sample Management System at the end of 2022. Through self-taught programming, the team organized members and upstream and downstream colleagues to discuss system functional requirements together and analyze system code design, interface design, and architecture in preparatory work. After 10 months of repeated debugging, modification, and refinement, the development of the Cell Bank Sample Management System was completed. The software system is divided into 8 core modules and enables full-process digital management of in-bank samples. The system has undergone comprehensive validation for safety, effectiveness, and compliance in accordance with GMP requirements. It went fully online on October 1, 2023.
